Basiliximab (αIL2R Mab) induction therapy combined with subtherapeutic doses of neoral and SDZ RAD successfully prevents allograft rejection in a nonhuman primate lung transplant model
1999 ◽
Vol 18
(1)
◽
pp. 73
Keyword(s):